Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical Trial
Zhao, Yan; Li, Jing-Yi; Yang, Bin; Ding, Yang-Feng; Wu, Li-Ming; Zhang, Li-Tao; Wang, Jin-Yan; Lu, Qian-Jin; Zhang, Chun-Lei; Zhang, Fu-Ren; Zhu, Xiao-Hong; Li, Yu-Mei; Tao, Xiao-Hua; Diao, Qing-Chun; Li, Lin-Feng; Lu, Jian-Yun; Man, Xiao-Yong; Li, Fu-Qiu; Xia, Xiu-Juan; Song, Jiao-Ran; Jia, Ying-Min; Zhang, Li-Bo; Chen, Bo; Zhang, Jian-Zhong Share Save Association between systemic immune inflammation index, systemic inflammation response index and adult psoriasis: evidence from NHANESMa, Rui; Cui, Lian; Cai, Jiangluyi; Yang, Nan; Wang, Yuanyuan; Chen, Qianyu; Chen, Wenjuan; Peng, Chen; Qin, Hui; Ding, Yangfeng; Wang, Xin; Yu, Qian; Shi, Yuling Share Save Share Save Share Save A randomized, double-blind, placebo- controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areataZhou, Cheng; Yang, Xiumin; Yang, Bin; Yan, Guofu; Dong, Xiuqin; Ding, Yangfeng; Fan, Weixin; Li, Linfeng; Yang, Dingquan; Fang, Hong; Ji, Chao; Cheng, Hao; Zhang, Shoumin; Goh, Aik Han; Liu, Rongjun; Gu, Xiaoyu; Weng, Zaili; Foley, Peter; Sinclair, Rodney; Zhang, Jianzhong Share Save Share Save Treatment outcomes of secukinumab in adult patients with moderate-to-severe plaque psoriasis in China: A real-world multicenter retrospective studyDing, Yangfeng; Li, Wei; Guan, Xin; Liu, Na; Zhou, Ying; Li, Gaojie; Wang, Xiaohua; Wang, Zhidong; Xiao, Xiao; Yang, Bin; Lv, Chengzhi; Zhang, Chunlei; Shi, Yuling Share Save Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trialZhao, Yan; Zhang, Jianzhong; Yang, Bin; Li, Jingyi; Ding, Yangfeng; Wu, Liming; Zhang, Litao; Wang, Jinyan; Zhu, Xiaohong; Zhang, Furen; Tao, Xiaohua; Li, Yumei; Zhang, Chunlei; Li, Linfeng; Lu, Jianyun; Diao, Qingchun; Lu, Qianjin; Man, Xiaoyong; Li, Fuqiu; Xia, Xiujuan; Cheng, Hao; Jia, Yingmin; Zhao, Guoqing; Yan, Jinchun; Chen, Bo Share Save Randomized, Placebo-Controlled, Multicenter Clinical Study on the Efficacy and Safety of Lidocaine Patches in Chinese Patients with Postherpetic NeuralgiaWang, Aiping; Li, Hang; Xie, Zhihong; Li, Lingfeng; Jiang, Xian; Guo, Qing; Hu, Fengming; Zhang, Jianzhong; Cui, Yong; Ding, Yangfeng; Fang, Hong; Han, Xiuping; Guo, Shuping; Wang, Junlong; Ni, Na Share Save A randomized, double-blind phase III study to demonstrate the clinical similarity of biosimilar SCT630 to reference adalimumab in Chinese patients with moderate to severe plaque psoriasisYu, Chen; Zhang, Furen; Ding, Yangfeng; Li, Yumei; Zhao, Yi; Gu, Jun; Guo, Shuping; Pan, Weili; Jin, Hongzhong; Sun, Qing; Kang, Xiaojing; Yang, Qinping; Jiang, Xian; Song, Zhiqiang; Lu, Qianjin; Pang, Xiaowen; Kuang, Yehong; Deng, Danqi; Li, Yuzhen; Zhang, Chunlei; Tao, Juan; Xie, Liangzhi; Wang, Yan; Wang, Jieying; Wang, Gang Share Save Share Save Share Save Efficacy and Safety of SHR0302, a Highly Selective Janus Kinase 1 Inhibitor, in Patients with Moderate to Severe Atopic Dermatitis: A Phase II Randomized Clinical TrialZhao, Yan; Zhang, Litao; Ding, Yangfeng; Tao, Xiaohua; Ji, Chao; Dong, Xiuqin; Lu, Jianyun; Wu, Liming; Wang, Rupeng; Lu, Qianjin; Goh, Aik Han; Liu, Rongjun; Zhang, Zhiguo; Zhang, Jianzhong Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
